Amanda Pilla

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Cogent Biosciences (United States)(Current)

Amanda Pilla is an author at Cogent Biosciences (United States) specializing in pharmacotherapy, receptor tyrosine kinase signaling, and preliminary investigation.

Publications per year

2022–2022

Publications

Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent <i>KIT</i> D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM)

Daniel J. DeAngelo, Vinod Pullarkat, Miguel Piris‐Villaespesa et al. · Blood · 2022 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +15

1–1 of 1